Zura Bio
ZURA
25 hedge funds and large institutions have $48.5M invested in Zura Bio in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
884% more capital inflows, than outflows
Capital inflows: $18.7M | Capital outflows: $1.9M
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
47% more funds holding
Funds holding: 17 → 25 (+8)
12.34% more ownership
Funds ownership: 23.27% → 35.61% (+12%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Owl Creek Asset Management
New York
|
+$4.44M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$2.78M |
| 3 |
Basso Capital Management
Stamford,
Connecticut
|
+$2.47M |
| 4 |
Prelude Capital Management
New York
|
+$1.48M |
| 5 |
Whitebox Advisors
Minneapolis,
Minnesota
|
+$1.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Oaktree Capital Management
Los Angeles,
California
|
-$1.47M |
| 2 |
Nexpoint Asset Management
Dallas,
Texas
|
-$306K |
| 3 |
Glazer Capital
New York
|
-$122K |
| 4 |
Wolverine Asset Management
Chicago,
Illinois
|
-$1K |
ZURA Hedge Fund Activity: Q4 2021 in Review
25 of the 6,524 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q4 2021, worth a combined $48.5M — up 54% from $31.6M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new ZURA positions and 3 closed out — a net gain of 8 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Owl Creek Asset Management, opening a new position worth an estimated $4.44M. The largest seller was Oaktree Capital Management, exiting entirely with an estimated $1.47M sold.
- 25 institutional investors held Zura Bio (ZURA) as of Q4 2021, up from 17 in Q3 2021.
- Funds reported $48.5M of Zura Bio stock for Q4 2021, up 54% quarter-over-quarter.
- 11 funds opened new Zura Bio positions in Q4 2021 and 3 closed out, a net change of +8 holders.
- The largest Zura Bio buyer in Q4 2021 was Owl Creek Asset Management, an estimated $4.44M added.
- The largest Zura Bio seller in Q4 2021 was Oaktree Capital Management, an estimated $1.47M sold.
Based on aggregated 13F filings for Q4 2021.